First-in-human results of NGF enhancer KRX-0501 for the treatment of neurological disorders Nov. 24, 2008
Memory completes enrollment in phase II trial of MEM-3454 in CI associated with schizophrenia Nov. 21, 2008
Positive results emerge from phase III ALO-01 study in patients with osteoarthritis pain Nov. 21, 2008